Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: Involvement of μ- and κ-opioid receptors

European Journal of Pharmacology

Volumn 318, Issue 1, 1996, Pages 11-16

  Reche, Ignacio ^a   Fuentes, José A ^a   Ruiz Gayo, Mariano ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 Tetrahydrocannabinol; Funaltrexamine; Analgesia; DAMGO ( D Ala2,N Me Phe4,Gly ol5 enkephalin); Dynorphin; Morphine; Nor binaltorphimine; Opioid; SR 141,716 A

Indexed keywords

BETA FUNALTREXAMINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; DRONABINOL; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NORBINALTORPHIMINE; OPIATE ANTAGONIST; RIMONABANT;

ANALGESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESIA; ANALGESICS, OPIOID; ANIMALS; BINDING SITES; DRUG SYNERGISM; MALE; MICE; MORPHINE; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; TETRAHYDROCANNABINOL;

EID: 0030604225     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00752-2     Document Type: Article

References (27)

1. 1 receptor stimulation, Eur. J. Pharmacol. 216, 157.
2. 9-tetrahydrocannabinol, Eur. J. Pharmacol. 36, 259.
3. Bhargava, H.N., 1976b, Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice, Psychopharmacology 49, 267.
4. Bloom, A.S., W.L. Dewey, L.S. Harris and K.K. Brosius, 1977, 9-Nor-9β-hydroxyhexahydrocannabinol, a cannabinoid with potent antinociceptive activity: comparisons with morphine, J. Pharmacol. Exp. Ther. 200, 263.
5. D'Amour, F.E. and D.L. Smith, 1941, A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther. 72, 74.
6. Devane, W.A., L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, G. Griffin, D. Gibson, A. Mandelbaum, A. Etinger and R. Mechoulam, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science 258, 1946.
7. Dewey, W.L., 1986, Cannabinoid pharmacology, Pharmacol. Rev. 38, 151.
8. Di Marzo, V., A. Fontana, H. Cadas, S. Schinelli, G. Cimino, J.C. Schwartz and D. Pomelli, 1994, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature 372, 686.
9. Eddy, N.B. and D. Liembach, 1953, Synthetic analgesic (II): diethylbutenyl and dithienylbutylamines, J. Pharmacol. Exp. Ther. 107, 385.
10. Fujimoto, J.M. and B. Holmes, 1990, Systemic single dose morphine pretreatment desensitizes mice to the spinal antianalgesic action of dynorphin A (1-17), J. Pharmacol. Exp. Ther. 254, 1.
11. Haley, T.J. and W.G. McCormick, 1957, Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse, Br. J. Pharmacol. 12, 12.
12. Hylden, J.L.K and G.L. Wilcox, 1980, Intrathecal morphine in mice: a new technique, Eur. J. Pharmacol. 67, 313.
13. Litchfield, J.T. and F. Wilcoxon, 1949, A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther. 96, 99.
14. Mailleux, P. and J.J. Vanderhaeghen, 1992, Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding autoradiography and in situ hybridization histochemistry, Neuroscience 48, 655.
15. Millan, M.J., 1990, κ-Opioid receptors and analgesia, Trends Pharmacol. Sci. 11, 70.
16. Portoghese, P.S., A.W. Lipkowski and A.E. Takemori, 1987, Bimorphinans as highly selective, potent κ opioid receptor antagonist, J. Med. Chem. 30, 238.
17. 9-tetrahydrocannabinol-induced analgesia in mice, Eur. J. Pharmacol. 301, 75.
18. Rinaldi-Carmona, M., F. Brth, M. Héaulme, D. Shire, B. Calandra, C. Congy, S. Martínez, K.J. Maruani, G. Néliat, D. Caput, P. Ferrara, P. Soubrié, J.C. Brelière and G. Le Fur, 1994, SR 141716A, a potent and selective antagonist of the brain cannabinoid receptor, FEBS Lett. 350, 240.
19. Roerig, S.C. and J.M. Fujimoto, 1989, Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice, J. Pharmacol. Exp. Ther. 249, 762.
20. 9-tetrahydrocannabinol and kappa opioids in mice, J. Pharmacol. Exp. Ther. 268, 1381.
21. Takemori, A.E., B.Y. Ho, J.S. Naeseth and P.S. Portoghese, 1988, Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays, J. Pharmacol. Exp. Ther. 246, 255.
22. 9-tetrahydrocannabinol in rats, Eur. J. Pharmacol. 70, 219.
23. Vaysse, P.J.J., E.L. Gardner and R.S. Zukin, 1987, Modulation of rat brain opioid receptors by cannabinoids, J. Pharmacol. Exp. Ther. 241, 534.
24. Ward, S.J., P.S. Portoghese and A.E. Takemori, 1982, Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine, J. Pharmacol. Exp. Ther. 220, 494.
25. Welch, S.P. 1993, Blockade of cannabinoid induced antinociception by binaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice, J. Pharmacol. Exp. Ther. 265, 633.
26. Welch, S.P. and D.L. Stevens, 1992, Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice, J. Pharmacol. Exp. Ther. 262, 10.
27. Welch, S.P., C. Thomas and G.S. Patrick, 1995, Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine, J. Pharmacol. Exp. Ther. 272, 310.